Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


18.12.2017

8 Antimicrob Agents Chemother
2 Clin Infect Dis
2 Infect Control Hosp Epidemiol
1 Int J Antimicrob Agents
1 J Antimicrob Chemother
1 J Clin Microbiol
2 J Infect Chemother
13 J Infect Dis
1 J Med Microbiol
2 JAMA
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. DUPONT H, Choinier P, Roche D, Adiba S, et al
    Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  2. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Tolerance to caspofungin in Candida albicans is associated with at least three distinctive mechanisms that govern expression of FKS genes and cell wall remodeling.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.00071.
    PubMed     Text format     Abstract available

  3. PFALLER MA, Huband MD, Rhomberg PR, Flamm RK, et al
    Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  4. SNESRUD E, Ong AC, Corey B, Kwak YI, et al
    Analysis of Serial Isolates of mcr-1-Positive Escherichia coli Reveals a Highly Active ISApl1 Transposon.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  5. TURANO H, Gomes F, Barros-Carvalho GA, Lopes R, et al
    Tn6350, a Novel Transposon Carrying Pyocin S8 Genes Encoding a Bacteriocin with Activity against Carbapenemase-Producing Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  6. SADER HS, Castanheira M, Huband M, Jones RN, et al
    WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  7. SHIELDS RK, Nguyen MH, Press EG, Chen L, et al
    In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  8. YANG YQ, Li YX, Song T, Yang YX, et al
    Colistin Resistance Gene mcr-1 and Its Variant in Escherichia coli Isolates from Chickens in China.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  9. LIN MY, Hayden MK, Lyles RD, Lolans K, et al
    Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus among Adult Intensive Care Unit Patients following State-Mandated Active Surveillance.
    Clin Infect Dis. 2017 Dec 7. pii: 4706267. doi: 10.1093/cid/cix1056.
    PubMed     Text format     Abstract available

  10. WOUDT SHS, de Greeff SC, Schoffelen AF, Vlek ALM, et al
    Antibiotic resistance and the risk of recurrent bacteremia.
    Clin Infect Dis. 2017 Dec 7. pii: 4706269. doi: 10.1093/cid/cix1076.
    PubMed     Text format     Abstract available


    Infect Control Hosp Epidemiol

  11. SOLTER E, Adler A, Rubinovitch B, Temkin E, et al
    Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.
    Infect Control Hosp Epidemiol. 2017 Dec 15:1-5. doi: 10.1017/ice.2017.
    PubMed     Text format     Abstract available

  12. MCDERMOTT H, Skally M, O'Rourke J, Humphreys H, et al
    Vancomycin-Resistant Enterococci (VRE) in The Intensive Care Unit in a Nonoutbreak Setting: Identification of Potential Reservoirs and Epidemiological Associations Between Patient and Environmental VRE.
    Infect Control Hosp Epidemiol. 2017 Dec 14:1-6. doi: 10.1017/ice.2017.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  13. CHUSRI S, Sakarunchai I, Kositpantawong N, Panthuwong S, et al
    Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017 Dec 11. pii: S0924-8579(17)30436.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  14. CABELLO FC, Godfrey HP
    Comment on: Transferable resistance to colistin: a new but old threat.
    J Antimicrob Chemother. 2017;72:636-637.
    PubMed     Text format    


    J Clin Microbiol

  15. KNETSCH CW, Kumar N, Forster SC, Connor TR, et al
    Zoonotic transfer of Clostridium difficile harboring antimicrobial resistance between farm animals and humans.
    J Clin Microbiol. 2017 Dec 13. pii: JCM.01384-17. doi: 10.1128/JCM.01384.
    PubMed     Text format     Abstract available


    J Infect Chemother

  16. OGIHARA S, Saito R, Sawabe E, Kozakai T, et al
    Molecular typing of methicillin-resistant Staphylococcus aureus: Comparison of PCR-based open reading frame typing, multilocus sequence typing, and Staphylococcus protein A gene typing.
    J Infect Chemother. 2017 Dec 7. pii: S1341-321X(17)30279.
    PubMed     Text format     Abstract available

  17. KAWASAKI Y, Matsubara K, Takahashi H, Morita M, et al
    Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
    J Infect Chemother. 2017 Dec 7. pii: S1341-321X(17)30274.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. SHAFER RW
    Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  27. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  28. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  29. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Microbiol

  31. KULKARNI SV, Bala M, Muqeeth SA, Sasikala G, et al
    Antibiotic susceptibility pattern of Neisseria gonorrhoeae strains isolated from five cities in India during 2013-2016.
    J Med Microbiol. 2017 Dec 12. doi: 10.1099/jmm.0.000662.
    PubMed     Text format     Abstract available


    JAMA

  32. MORGAN DJ, Wenzel RP, Bearman G
    Contact Precautions for Multidrug-Resistant Organisms-Reply.
    JAMA. 2017;318:2258.
    PubMed     Text format    

  33. PETERSON LR
    Contact Precautions for Multidrug-Resistant Organisms.
    JAMA. 2017;318:2257.
    PubMed     Text format    


    PLoS One

  34. HECKEL M, Geissdorfer W, Herbst FA, Stiel S, et al
    Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) at a palliative care unit: A prospective single service analysis.
    PLoS One. 2017;12:e0188940.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: